Changzhou Sunlight Pharmaceutical Co., Ltd.
About Changzhou Sunlight Pharmaceutical Co., Ltd.
Certifications
Categories

-
CN
-
2015On CPHI since
-
3Certificates
-
250 - 499Employees
Company types
Primary activities
Meet us at
CPHI Japan 2025
East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan
09 Apr 2025 – 11 Apr 2025
CPHI & PMEC China 2025
Shanghai New International Expo Center
24 Jun 2025 - 26 Jun 2025
CPHI Korea 2025
COEX, Seoul, Korea
26 Aug 2025 - 28 Aug 2025
Products from Changzhou Sunlight Pharmaceutical Co., Ltd. (46)
-
Product 3-Aminobenzoic acid
CAS:99-05-8 -
Product 4-aminobenzoic acid; P-aminobenzoic acid
cas No. 150-13-0;intermediate -
Product 4-Hydroxyindole
Cas No. 2380-94-1 -
Product 4-Trifluoromethyl salicylic acid
intermediate -
Product 5-Bromo-2-chlorobenzoic acid
pharmaceutical intermediate -
Product 5-Bromo-2-chlorobenzoic acid
intermediate -
Product Alogliptin
CAS:850649-62-6 -
Product Avobenzone
Changzhou sunlight pharmaceutical co ltd manufactures apis, pharmaceutical intermediate, finished medicines which includes avobenzone. It belongs to synthetic intermediates products category. Contact us for more information. -
Product Benzocaine
API, GMP certificate, COS certificate, DMF -
Product Benzocaine
EP, USP, JP, BP.GMP certificate, COS certificate, DMF -
Product Benzocaine
API, pharmaceutical intermediate, for local anaesthesia -
Product Benzocaine
API, pharmaceutical intermediate.
Recently Visited
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance